{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["hepatocellular carcinoma", "invasion", "migration", "ozonated water", "proliferation"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "36798740", "DateRevised": {"Year": "2023", "Month": "02", "Day": "18"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2023", "Month": "02", "Day": "10"}], "ELocationID": ["10.2147/JHC.S394074"], "Journal": {"ISSN": "2253-5969", "JournalIssue": {"Volume": "10", "PubDate": {"Year": "2023"}}, "Title": "Journal of hepatocellular carcinoma", "ISOAbbreviation": "J Hepatocell Carcinoma"}, "ArticleTitle": "Ozonated Water Inhibits Hepatocellular Carcinoma Invasion and Metastasis by Regulating the HMGB1/NF-\u03baB/STAT3 Signaling Pathway.", "Pagination": {"StartPage": "203", "EndPage": "215", "MedlinePgn": "203-215"}, "Abstract": {"AbstractText": ["Hepatocellular carcinoma (HCC) is one of the deadliest cancers worldwide. High-mobility group box 1 (HMGB1), a highly conserved chromosome protein, is considered as a potential therapeutic target and novel biomarker because of its regulation in the proliferation and metastasis of HCC. Ozone has been shown to be beneficial in the treatment of cancer. The objective of this study was to explore the effects and molecular mechanism of ozonated water on the proliferation, migration, and invasion of BEL7402 HCC cells.", "We assessed cell proliferation using a CCK-8 assay kit and flow cytometry; we performed wound healing and transwell assays to evaluate the effects of ozonated water treatment on cell invasion and migration. We determined reactive oxygen species (ROS) values by flow cytometry and used ELISAs to detect cytokines HMGB1, IL-6, and TNF-\u03b1. In addition, we assessed mRNA and protein cytokine expressions using RT-qPCR and Western blot.", "Ozonated water decreased the viability of the HCC cells; the IC50 of ozonated water at 24 h was approximately 1.5 \u03bcg/mL. Compared with control groups, ozone treated cells revealed reduced mobility on wound healing assays and decreased invasion in transwell assays. HMGB1, IL-6, and TNF-\u03b1 cytokines were found at lower levels in ozone treated cells than in control cells. Ozonated water-induced ROS accumulation. Likewise, the expressions of phosphorylated nuclear factor Kappa B (NF-\u03baB), p65, NF-\u03baB, P-STAT3, IL-6, JAK2, Slug, Twist, vimentin, MMP-2, MMP-9, and HMGB1 were decreased in the treated cells.", "Our findings suggest that ozonated water inhibits the proliferation, invasion, and metastasis of HCC cells via regulation of the HMGB1/NF-\u03baB/STAT3 signaling pathway."], "CopyrightInformation": "\u00a9 2023 Tang et al."}, "AuthorList": [{"Identifier": ["0000-0002-2555-2042"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Vascular and Interventional Radiology, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China."}], "LastName": "Tang", "ForeName": "Shuiying", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Interventional Radiology and Pathology, Nanfang Hospital, Department of Pathology, Southern Medical University, Guangzhou, 510515, People's Republic of China."}], "LastName": "Xu", "ForeName": "Bihong", "Initials": "B"}, {"Identifier": ["0000-0001-7367-5701"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Vascular and Interventional Radiology, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China."}], "LastName": "Pang", "ForeName": "Huajin", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Vascular and Interventional Radiology, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China."}], "LastName": "Xiao", "ForeName": "Lijun", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Vascular and Interventional Radiology, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China."}], "LastName": "Mei", "ForeName": "Quelin", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Vascular and Interventional Radiology, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China."}], "LastName": "He", "ForeName": "Xiaofeng", "Initials": "X"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "J Hepatocell Carcinoma", "NlmUniqueID": "101674775", "ISSNLinking": "2253-5969"}, "CoiStatement": "The authors report no conflicts of interest in this work."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ferenci P, Fried M, Labrecque D, et al. Hepatocellular carcinoma (HCC): a global perspective. J Clin Gastroenterol. 2010;44:239\u2013245.", "ArticleIdList": ["20216082"]}, {"Citation": "Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69\u201390. doi:10.3322/caac.20107", "ArticleIdList": ["10.3322/caac.20107", "21296855"]}, {"Citation": "Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u2013249. doi:10.3322/caac.21660", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "Han K, Kim JH. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system. World J Gastroenterol. 2015;21:10327\u201310335. doi:10.3748/wjg.v21.i36.10327", "ArticleIdList": ["10.3748/wjg.v21.i36.10327", "PMC4579879", "26420959"]}, {"Citation": "Johnson TM, Overgard EB, Cohen AE, DiBaise JK. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908\u2013943. doi:10.1016/j.jhep.2011.12.001", "ArticleIdList": ["10.1016/j.jhep.2011.12.001", "22424438"]}, {"Citation": "Smith NL, Wilson AL, Gandhi J, Vatsia S, Khan SA. Ozone therapy: an overview of pharmacodynamics, current research, and clinical utility. Med Gas Res. 2017;7:212\u2013219. doi:10.4103/2045-9912.215752", "ArticleIdList": ["10.4103/2045-9912.215752", "PMC5674660", "29152215"]}, {"Citation": "Sweet F, Kao MS, Lee SC, Hagar WL, Sweet WE. Ozone selectively inhibits growth of human cancer cells. Science. 1980;209:931\u2013933. doi:10.1126/science.7403859", "ArticleIdList": ["10.1126/science.7403859", "7403859"]}, {"Citation": "Schulz S, Haussler U, Mandic R, et al. Treatment with ozone/oxygen-pneumoperitoneum results in complete remission of rabbit squamous cell carcinomas. Int J Cancer. 2008;122:2360\u20132367. doi:10.1002/ijc.23382", "ArticleIdList": ["10.1002/ijc.23382", "18224691"]}, {"Citation": "Teke K, Ozkan TA, Cebeci OO, et al. Preventive effect of intravesical ozone supplementation on n-methyl-n-nitrosourea-induced non-muscle invasive bladder cancer in male rats. Exp Anim. 2017;66:191\u2013198. doi:10.1538/expanim.16-0093", "ArticleIdList": ["10.1538/expanim.16-0093", "PMC5543239", "28228618"]}, {"Citation": "Lotfi R, Herzog GI, DeMarco RA, et al. Eosinophils oxidize damage-associated molecular pattern molecules derived from stressed cells. J Immunol. 2009;183:5023\u20135031. doi:10.4049/jimmunol.0900504", "ArticleIdList": ["10.4049/jimmunol.0900504", "19794066"]}, {"Citation": "Jiang J, Wang GZ, Wang Y, Huang HZ, Li WT, Qu XD. Hypoxia-induced HMGB1 expression of HCC promotes tumor invasiveness and metastasis via regulating macrophage-derived IL-6. Exp Cell Res. 2018;367:81\u201388. doi:10.1016/j.yexcr.2018.03.025", "ArticleIdList": ["10.1016/j.yexcr.2018.03.025", "29571949"]}, {"Citation": "Venereau E, Casalgrandi M, Schiraldi M, et al. Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med. 2012;209:1519\u20131528. doi:10.1084/jem.20120189", "ArticleIdList": ["10.1084/jem.20120189", "PMC3428943", "22869893"]}, {"Citation": "Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 2005;5:749\u2013759. doi:10.1038/nri1703", "ArticleIdList": ["10.1038/nri1703", "16175180"]}, {"Citation": "Karin M, Cao Y, Greten FR, Li ZW. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer. 2002;2:301\u2013310. doi:10.1038/nrc780", "ArticleIdList": ["10.1038/nrc780", "12001991"]}, {"Citation": "Nomura A, Banerjee S, Chugh R, et al. CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer. Oncotarget. 2015;6:8313\u20138322.", "ArticleIdList": ["PMC4480754", "25829252"]}, {"Citation": "Zhang Y, Zhao Y, Ran Y, Guo J, Cui H, Liu S. Alantolactone exhibits selective antitumor effects in HELA human cervical cancer cells by inhibiting cell migration and invasion, G2/M cell cycle arrest, mitochondrial mediated apoptosis and targeting Nf-kB signalling pathway. J Buon. 2019;24:2310\u20132315.", "ArticleIdList": ["31983099"]}, {"Citation": "Song R, Song H, Liang Y, et al. Reciprocal activation between ATPase inhibitory factor 1 and NF-kappaB drives hepatocellular carcinoma angiogenesis and metastasis. Hepatology. 2014;60:1659\u20131673.", "ArticleIdList": ["25042864"]}, {"Citation": "Yang Q, Zhang J, Xu S, et al. Knockdown of PHF5A inhibits migration and invasion of HCC cells via downregulating NF-kappaB Signaling. Biomed Res Int. 2019;2019:1621854. doi:10.1155/2019/1621854", "ArticleIdList": ["10.1155/2019/1621854", "PMC6350539", "30766880"]}, {"Citation": "Chiang IT, Liu YC, Wang WH, et al. Sorafenib inhibits TPA-induced MMP-9 and VEGF expression via suppression of ERK/NF-kappaB pathway in hepatocellular carcinoma cells. Vivo. 2012;26:671\u2013681.", "ArticleIdList": ["22773582"]}, {"Citation": "Hsu FT, Liu YC, Chiang IT, et al. Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-kappaB signaling. Int J Oncol. 2014;45:177\u2013188. doi:10.3892/ijo.2014.2423", "ArticleIdList": ["10.3892/ijo.2014.2423", "24807012"]}, {"Citation": "Tsai JJ, Pan PJ, Hsu FT. Regorafenib induces extrinsic and intrinsic apoptosis through inhibition of ERK/NF-kappaB activation in hepatocellular carcinoma cells. Oncol Rep. 2017;37:1036\u20131044. doi:10.3892/or.2016.5328", "ArticleIdList": ["10.3892/or.2016.5328", "28000898"]}, {"Citation": "Wong VW, Yu J, Cheng AS, et al. High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B. Int J Cancer. 2009;124:2766\u20132770. doi:10.1002/ijc.24281", "ArticleIdList": ["10.1002/ijc.24281", "19267406"]}, {"Citation": "Zhong Z, Wen Z, Darnell JJ. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science. 1994;264:95\u201398. doi:10.1126/science.8140422", "ArticleIdList": ["10.1126/science.8140422", "8140422"]}, {"Citation": "Feng DY, Zheng H, Tan Y, Cheng RX. Effect of phosphorylation of MAPK and Stat3 and expression of c-fos and c-jun proteins on hepatocarcinogenesis and their clinical significance. World J Gastroenterol. 2001;7:33\u201336. doi:10.3748/wjg.v7.i1.33", "ArticleIdList": ["10.3748/wjg.v7.i1.33", "PMC4688697", "11819729"]}, {"Citation": "Jiang R, Tan Z, Deng L, et al. Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3. Hepatology. 2011;54:900\u2013909. doi:10.1002/hep.24486", "ArticleIdList": ["10.1002/hep.24486", "21674558"]}, {"Citation": "Calvisi DF, Ladu S, Gorden A, et al. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. Gastroenterology. 2006;130:1117\u20131128. doi:10.1053/j.gastro.2006.01.006", "ArticleIdList": ["10.1053/j.gastro.2006.01.006", "16618406"]}, {"Citation": "Li WC, Ye SL, Sun RX, et al. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3. Clin Cancer Res. 2006;12:7140\u20137148. doi:10.1158/1078-0432.CCR-06-0484", "ArticleIdList": ["10.1158/1078-0432.CCR-06-0484", "17145839"]}, {"Citation": "Ashizawa Y, Kuboki S, Nojima H, et al. OLFM4 Enhances STAT3 activation and promotes tumor progression by inhibiting GRIM19 expression in human hepatocellular carcinoma. Hepatol Commun. 2019;3:954\u2013970. doi:10.1002/hep4.1361", "ArticleIdList": ["10.1002/hep4.1361", "PMC6601327", "31304451"]}, {"Citation": "He G, Yu GY, Temkin V, et al. Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. Cancer Cell. 2010;17:286\u2013297. doi:10.1016/j.ccr.2009.12.048", "ArticleIdList": ["10.1016/j.ccr.2009.12.048", "PMC2841312", "20227042"]}, {"Citation": "Meng F, Zhang S, Song R, et al. NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-kappaB/miR-188-3p pathways. Ebiomedicine. 2019;44:237\u2013249. doi:10.1016/j.ebiom.2019.05.053", "ArticleIdList": ["10.1016/j.ebiom.2019.05.053", "PMC6606561", "31176678"]}, {"Citation": "Zhang C, Guo F, Xu G, Ma J, Shao F. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells. Oncol Rep. 20151872;33:1872.", "ArticleIdList": ["25653024"]}, {"Citation": "Zhao Y, Yao J, Wu XP, et al. Wogonin suppresses human alveolar adenocarcinoma cell A549 migration in inflammatory microenvironment by modulating the IL-6/STAT3 signaling pathway. Mol Carcinog. 2015;54(1):E81\u201393. doi:10.1002/mc.22182", "ArticleIdList": ["10.1002/mc.22182", "24976450"]}, {"Citation": "Bai Y, Lu H, Lin C, et al. Sonic hedgehog-mediated epithelial-mesenchymal transition in renal tubulointerstitial fibrosis. Int J Mol Med. 2016;37:1317\u20131327. doi:10.3892/ijmm.2016.2546", "ArticleIdList": ["10.3892/ijmm.2016.2546", "27035418"]}, {"Citation": "Zheng QM, Lu JJ, Zhao J, Wei X, Wang L, Liu PS. Periostin facilitates the epithelial-mesenchymal transition of endometrial epithelial cells through ILK-akt signaling pathway. Biomed Res Int. 2016;(2016):9842619. doi:10.1155/2016/9842619", "ArticleIdList": ["10.1155/2016/9842619", "PMC4808541", "27034956"]}, {"Citation": "Redmer T. Deciphering mechanisms of brain metastasis in melanoma - The gist of the matter. Mol Cancer. 2018;17:106. doi:10.1186/s12943-018-0854-5", "ArticleIdList": ["10.1186/s12943-018-0854-5", "PMC6064184", "30053879"]}, {"Citation": "Xiong H, Hong J, Du W, et al. Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition. J Biol Chem. 2012;287:5819\u20135832. doi:10.1074/jbc.M111.295964", "ArticleIdList": ["10.1074/jbc.M111.295964", "PMC3285352", "22205702"]}, {"Citation": "Shiau DJ, Kuo WT, Davuluri G, et al. Hepatocellular carcinoma-derived high mobility group box 1 triggers M2 macrophage polarization via a TLR2/NOX2/autophagy axis. Sci Rep. 2020;10(1):13582. doi:10.1038/s41598-020-70137-4", "ArticleIdList": ["10.1038/s41598-020-70137-4", "PMC7423894", "32788720"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "10", "Day": "20"}, {"Year": "2023", "Month": "1", "Day": "17"}, {"Year": "2023", "Month": "2", "Day": "17", "Hour": "2", "Minute": "13"}, {"Year": "2023", "Month": "2", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "18", "Hour": "6", "Minute": "1"}, {"Year": "2023", "Month": "2", "Day": "10"}], "PublicationStatus": "epublish", "ArticleIdList": ["36798740", "PMC9926998", "10.2147/JHC.S394074", "394074"]}}], "PubmedBookArticle": []}